Applied Health Economics and Health Policy

Article	Citations
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review	226
Partnerships in Public Health Economics: Reflective Lessons from UK Obesity Research	113
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–2020	55
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil	43
Improving Consumer Engagement in Health Technology Assessment and Decision Making: Lessons from ‘Values in Science’	39
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study	38
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China	36
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach	30
The Cost Effectiveness of Treatment Strategies for Depression in Ethiopia: A Multiple Cohort Markov Model Analysis	30
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context	28
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities	28
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches	26
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework	26
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines	24
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis	23
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand	22
The Economics of Antibiotic Resistance: A Systematic Review and Meta-analysis Based on Global Research	20
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions	18
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom	18
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies	18
Politicised Changes to the NICE Threshold Risk Making Cost-Effectiveness Analysis Performative, Not Informative	17
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?	17
Acknowledgement to Reviewers	16
The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates	15
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana	15

A Cost–Utility Analysis of Surgical Site Infection Prevention: Broadening the Scope	15
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?	15
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis	15
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective	15
How is Value Defined in Molecular Testing in Cancer? A Scoping Review	15
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach	14
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients	14
The Price of Speed: Estimating the Impact of List Prices on Time to Availability of New Medicines in 18 European Countries	14
Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	14
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon	13
Economic Evaluation of Bruton’s Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukaemia in South Africa	13
Contextual Factors that Influence Antibiotic Prescribing: A Discrete Choice Experiment of GP Registrars	13
Quality-Adjusted Life Expectancy and Cost-Effectiveness Thresholds in Three High-Income Regions in Asia	12
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts	12
Social Costs of Smoking in the Czech Republic	12
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India	12
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study	11
Societal Preferences for Assessment Pathways of Rare Disease Drugs: A Discrete Choice Experiment	11
Young People’s Preferences for Web-Based Mental Health Interventions for Managing Anxiety and Depression: A Discrete Choice Experiment	11
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making	11
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	11
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?	11
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models	11
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes	11
Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers	11
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040	11
Trump’s Drug Pricing Order and the Domestic Economic Trade-Off	10
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective	10
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature	10
Collaborating for Affordable Patient Access to Medicines: Review of the First Decade of the Beneluxa Initiative in Pharmaceutical Policy	10
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges	10
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance	10
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment	10
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older	10
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study	10
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis	10
Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer	9
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value	9
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets	9
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework	9
Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review	9
A Systematic Review of Economic Evaluations on Interventions Targeting Insomnia or Hypersomnia	8
Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer Screening	8
Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases	7
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review	7
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework	7
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold	7
Headroom Analysis for Early Economic Evaluation: A Systematic Review	7
EQ-5D-5L Population Norms for Italy	7
Costs and Budget Impact of a Health System Strengthening Intervention for Hypertension and Cardiovascular Disease Care in Ghana	7

Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment	7
The Price of National Pharmaceutical Pricing in the EU: A Proposal for “Common Procurement”	7
A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America	7
Estimated Carbon Savings from Changing Surgical Trends in Primary Elective Total Hip Arthroplasty in England: A Retrospective Observational Study	7
New Horizons? Assessing General Public Preferences for a Wellbeing Economy in the Post-COVID-19 World	6
The Impact of Alteplase Coverage on Health Equity for the Treatment of Ischemic Stroke in the USA: A Distributional Cost-Effectiveness Analysis	6
Correction: Economic Evaluations of Robotic-Assisted Surgery: Methods, Challenges and Opportunities	6
The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review	6
Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review	6
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration	6
Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals	6
Structured Expert Elicitation to Inform Long-Term Survival Extrapolations in Advanced Renal Cell Carcinoma	6
Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment	6
Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe	6
Genetic Test Utilization and Cost among Families of Children Evaluated for Genetic Conditions: An Analysis of USA Commercial Claims Data	6
Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On	6
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment	6
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends	6
Utilising Health Technology Assessment to Develop Managed Access Protocols to Facilitate Drug Reimbursement in Ireland	6
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide	6
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany	6
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review	6
Preferences for Digital Mental Health Services in Urban China: A Discrete Choice Experiment	6
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review	5
Economic Epidemiology: A Framework to Study Interactions of Epidemics and the Economy	5
The Increasing Value of Environmental Sustainability Assessments in Healthcare Policy and Technology Evaluation	5
Cost-Effectiveness and Public Health Impact of Newborn Screening for Spinal Muscular Atrophy in France	5
The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals	5
Willingness to Pay per QALY: A Systematic Review of Demand-Side Valuations with a Focus on Age and Disease Severity	5
Estimating System-Wide Healthcare Costs Using a Health System Model: Application to the Thanzi La Onse Model of Malawi	5
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia	5
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China	5
Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China	5
Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review	4
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study	4
The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review	4
Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden	4
The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review	4
Cost-Effectiveness of Adult Hepatitis A Vaccination Strategies in Korea Under an Aging Susceptibility Profile	4
Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation	4
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit	4
Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations	4
Should the Spanish National Health System Invest in Psychotherapy for Depression? A Microsimulation Cost-Utility Study to Estimate the Economically Justifiable Price of Cognitive Behavioral Therapy Ve	4
The Short Form 6 Dimensions (SF-6D): Development and Evolution	4
Opportunities for CMS to Further Specify and Broaden Its Approach to Assessing Unmet Medical Need in the Context of the Medicare Drug Price Negotiation Program	4
Cost-Utility Analysis of TAVI Versus Surgery in Low-Risk Patients with Severe Aortic Stenosis in the UK	4
Predicting Health Utilities Using Health Administrative Data: Leveraging Survey-linked Health Administrative Data from Ontario, Canada	4
Agreement in Qualitative and Quantitative Assessments of Disease Severity: Evidence from Pharmaceutical Reimbursement in Sweden	4
Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study	4
Active Transport Health Model: Valuing the Health Benefits of Active Transport	3
A Systematic Review of Microsimulation Models in Cardiometabolic Disease: Model Calibration and Validation	3
myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology	3
How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry	3
The Cost-Effectiveness of Initiating Patients on Home Dialysis Compared with In-Centre Haemodialysis	3
The Gift of Time, How Do I Want to Spend It? Exploring Preferences for Time Allocation Among Women with and without a Breast Cancer Diagnosis	3
Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?	3
A Contingent Valuation Study for Use in Valuing Public Goods with Health Externalities: The Case of Street Pianos	3
Towards a Multi-sectoral Approach to Population Health: A Scoping Review of Cross-sectoral Evaluations of Health Interventions	3
Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions	3
Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”	3
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis	3
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA	3
Modelling Informal Carers’ Health-Related Quality of Life: Challenges for Economic Evaluation	3
An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology	3
Cost of Carbon in the Total Cost of a Healthcare Procedure: Example of Micro-Costing Study in a French Setting	3
Health Economic Evaluations of Breast Cancer Screening Strategies: A Systematic Review Focusing on Methodology and Quality Assessment	3
Healthcare Costs and Carbon Emissions of Stage III Melanoma Surveillance Imaging	3
Health Interventions May Have Divergent Impacts on Health and Economic Equity: A Case Study of the Community-Based Hypertension Improvement Project in Ghana	3
Australian Preferences for Prenatal Screening: A Discrete Choice Experiment Comparing Metropolitan and Rural/Regional Areas	3
Real-World Health and Economic Effects of a Large-Scale Outpatient Screening and Continuing Care Programme for Early Detection and Care of Microvascular Complications in Patients with Type 2 Diabetes	3
The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review	3
Alternative Payment Models for Innovative Medicines: A Framework for Effective Implementation	3
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022	3
Acknowledgement to Referees	3
Is the Use of Unanchored Matching-Adjusted Indirect Comparison Always Superior to Naïve Indirect Comparison on Survival Outcomes? A Simulation Study	3
Preferences of Women for Maternal Health Services in Sidama Region, Ethiopia: Discrete Choice Experiment	3
Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults	3
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach	3
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences	3
The Economic Cost of Obesity: A Cost-of-Illness Study in Greece	2

Policy Levers for First-Contact Healthcare Provider Choice: A Discrete Choice Experiment in Shanghai’s Hierarchical Medical System	2
The Inflation Reduction Act: Hope for Prescription Drug Prices in the USA	2
Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation	2
The False Economy of Seeking to Eliminate Delayed Transfers of Care: Some Lessons from Queueing Theory	2
Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government	2
The Italian Assessment System for Innovative Medicines: An 8-Year Retrospective Analysis of Outcomes, Criteria, Timelines and Funding Dynamics	2
Do the Poor Gain More? The Impact of Secondary-Care Expenditure on Health Inequality	2
Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?	2
GaitSmart Rehabilitation Exercise Programme for Gait and Mobility Issues: A NICE Medical Technologies Guidance	2
Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy	2
What Interventions are Cost Effective in Reducing Violence Against Women? A Scoping Review	2
Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	2
Data-Related and Methodological Challenges in Assessing the Cost-Effectiveness of Traditional and Genomic Newborn Screening Programs	2
Estimation of ‘spectrum value’: A discrete choice experiment to investigate the willingness-to-pay for narrow-spectrum based on other antimicrobial characteristics	2
Treatment Preferences of Adolescents and Young Adults with Depressive Symptoms: A Discrete Choice Experiment	2
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China	2
Action Plan to Better Approximate Reality in Cost-Effectiveness Analyses	2
Antimicrobial Resistance (AMR) Development Map: A Conceptual Map and a Tool to Support Economic Evaluation of AMR Interventions	2
Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review	2
The Impact of the Approach to Accounting for Age and Sex in Economic Models on Predicted Quality-Adjusted Life-Years	2
Cost of Low-Value Imaging Worldwide: A Systematic Review	2
Acknowledgement to Referees	2
A Multi-dimensional Framework of Valued Output for Primary Care in England	2
Are Drug Novelty Characteristics Associated With Greater Health Benefits?	2
Correction: Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance	2
A Systematic Review of Kidney Transplantation Decision Modelling Studies	2
The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review	2
Modelling Methods of Economic Evaluations of HIV Testing Strategies in Sub-Saharan Africa: A Systematic Review	2
Cost Effectiveness of Interventions for Perinatal Anxiety and/or Depression: A Systematic Review of Global Evidence	2
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis	2
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities	2
A Systematic Review of Modelling Approaches in Economic Evaluations of Treatments for Inherited Bleeding Disorders	2
Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections	2
Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes	2
Comment on: “Comparison of Caregiver and General Population Preferences for Dependency‑Related Health States”	2